Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 9,494

Document Document Title
WO2005049556A3
The subject matter of the invention is a process for the production of metal salts of trifluoromethane sulphonic acid by reacting trifluoromethane sulphonic acid with a metal alcoholate and the use thereof as esterification catalyst and/...  
WO/2005/102993A1
A process for the purification of aqueous acid solutions which can dispense with the step of removing chloride ions and which is reduced in the damage to an ion exchanger (such as an ion-exchange column) and thereby permits repeated use ...  
WO/2005/100307A2
A method for making the phosphonium sulfonate salt of generic formula (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 and q and r ar...  
WO/2005/095323A1
La présente invention concerne un procédé de préparation de composé ester activateur de blanchiment. Ce procédé consiste (A) à préparer un monoester d'acide gras, (B) à fabriquer un chloroformate par réaction de ce monoester d...  
WO/2005/092952A1
A process for sulfating alkoxylated amines, alkoxylated polyols, hydrophobic polyamine ethoxylate polymers, via the use of sulfuric acid.  
WO/2005/085187A1
Disclosed is a method for producing an &ohgr -fluorosulfonyl perfluoroalkyl vinyl ether represented by the general formula (2) below through specific steps (a)-(c) from an &ohgr -haloperfluoroalkyl sulfonyl fluoride represented by the ge...  
WO/2005/081777A2
Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or...  
WO/2005/082843A1
The present invention provides processes for the preparation of arylalkylsulfonyl halides and heteroarylalkylsufonyl halides of Formula: Ar-R-SO2-X, that are useful as intermediates in the preparation of pharmaceuticals.  
WO2004108636A3
A radioisotope labeled reagent includes a compound having the general formula (I) where a in each occurrence independently is a carbon mass number between 11 and 14 inclusive, b in each occurrence independently is a hydrogen mass number ...  
WO2005065164A3
A process for preparing fluorochemical monoisocyanates comprises reacting at least one fluorochemical alcohol represented by the formula CnF2n+1SO2NCH3 (CH2) mOH, wherein n = 2 to 5, and m = 2 to 4, with 4,4' -diphenylmethane diisocyanat...  
WO/2005/080323A1
The invention relates to an improved process for the manufacture of enantiomerically pure R-(+) or S-(+)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide by resolution of (R,S)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide with D-(-) or L...  
WO/2005/075416A1
In the present invention, amorphous tamsulosin hydrochloride, the process for preparation thereof by lyophilisation or spray-drying and the properties thereof are disclosed. Amorphous tamsulosin hydrochloride is useful in the preparation...  
WO/2005/075406A1
An adamantane derivative (I) having a structure represented by the general formula (I); an adamantane derivative (II) having a structure represented by the general formula (II); and a process for producing these adamantane derivatives. A...  
WO/2005/075073A1
The present invention is to provide a recyclable water-soluble transition metal complex catalyst which is a novel metal complex catalyst capable of producing an optically active alcohol from a ketone with good yield and good optical puri...  
WO/2005/075623A1
The present invention provides acylalkylisethionate esters useful in consumer products. The acylalkylisethionate esters are produced by reacting one or more carboxylic acids with one or more alkyl-substituted hydroxyalkyl sulfonates unde...  
WO/2005/075651A1
A low-cost and efficient industrial process for producing (S)-2-pentanol, (S)-2-hexanol, 1-methylalkylmalonic acid and 3-methylcarboxylic acid with high optical purity. There is provided a process for producing (S)-2-pentanol and (S)-2-h...  
WO/2005/075415A1
A method of preparation of (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide of formula I and its use for production tamsulosin. A protective group is introduced to N-[(1R)-2­(4-methoxyphenyl)-1-methylethyl]-N- [(1 R)-1-phenylethyl)...  
WO/2005/073182A1
A method for producing a fluorine-containing unsaturated sulfonyl fluoride represented by the chemical formula: RfSO2F (wherein Rf is as defined below) is characterized in that a fluorine-containing unsaturated sulfonyl chloride represen...  
WO/2005/073388A1
A process for producing an optically active 1,4-pentanediol which comprises asymmetrically reducing 5-hydroxy-2-pentanone, which is easily available at low cost. Also provided is a process for producing an optically active 1-substituted ...  
WO/2005/069751A2
Radicals with unpaired electrons are used to initiate a chain reaction that converts small hydrocarbons such as methane into oxygenated liquids. An initiator such as Marshall's acid is used to create methyl radicals. These radicals combi...  
WO/2005/068405A1
A process for producing phenyl-alkanes by paraffin dehydrogenation followed by olefin isomerization and then by alkylation of a phenyl compound by a lightly branched olefin is disclosed. An effluent of the alkylation section comprises pa...  
WO/2005/065164A2
A process for preparing fluorochemical monoisocyanates comprises reacting at least one fluorochemical alcohol represented by the formula CnF2n+1SO2NCH3 (CH2) mOH, wherein n = 2 to 5, and m = 2 to 4, with 4,4' -diphenylmethane diisocyanat...  
WO/2005/063700A1
The invention relates to a process for catalyzing the preparation of directly esterified fatty acid isethionate (DEFI) reaction using group 4 metal based catalyst (according to IUPAC). Directly esterified fatty acyl isethionate (DEFI) is...  
WO/2005/063701A1
The present invention relates to a new process for the preparation of optically pure (R)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide, which is an intermediate in the synthesis of tamsulosin.  
WO/2005/063702A1
In the present invention, the process for the preparation of tamsulosin hydrochloride and subsequent purification with thermal crystallisation to provide essentially pure tamsulosin hydrochloride is disclosed.  
WO/2005/061447A3
The production of alkylaryl compounds comprises the following stages: a) reaction of a C4/C5 olefin mixture on a metathesis catalyst to produce a C4-8 olefin mixture containing 2-pentene and the optional isolation of the C4-8 olefin mixt...  
WO/2005/061447A2
The production of alkylaryl compounds comprises the following stages: a) reaction of a C4/C5 olefin mixture on a metathesis catalyst to produce a C4-8 olefin mixture containing 2-pentene and the optional isolation of the C4-8 olefin mixt...  
WO/2005/058806A1
A method for producing chlorosulfonyl isocyanate wherein chlorocyanogen is reacted with sulfur trioxide to form chlorosulfonyl isocyanate, characterized in that chlorosulfonyl isocyanate or a fluid containing chlorosulfonyl isocyanate is...  
WO/2005/058810A1
A subject matter of the present invention is novel intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts, and also the associated preparation process.  
WO/2005/056521A1
Provided is a method of preparing an optically pure compound having formula 1 or its salts. The method includes: reacting ®-2-(4-methoxy-3-aminosulfonyl-phenyl)-1-methylethylamine or its salts with a compound selected form the group con...  
WO2005010011A3
Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in...  
WO/2005/051897A1
There is provided a process for the preparation of tamsulosin of formula 5, involving a coupling reaction in the presence of an aluminum reagent between an ester of formula 2A and (R)-5-(2-amino)propyl-2-methoxy-benzenesulfonamide of for...  
WO/2005/049556A2
The subject matter of the invention is a process for the production of metal salts of trifluoromethane sulphonic acid by reacting trifluoromethane sulphonic acid with a metal alcoholate and the use thereof as esterification catalyst and/...  
WO/2005/044795A1
The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3- &lcub [3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]c arbonyl&rcub cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro- 2H-pyran-4-yl...  
WO2005019164A3
The present invention relates to a novel process for the preparation of phenethanolamine derivatives, which process comprises the step of reacting a compound of formula RO(CH2)nBRR with a compound of formula (II).  
WO2005014539A3
HMGCo-A reductase inhibitor compounds of formula (I) useful as hypocholesterolemic and hypolipidemic compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compo...  
WO2004110976A3
There is provided a process for the preparation of aromatic amines of Formula (1): where R is optionally substituted aryl and R is optionally substituted hydrocarbyl, which comprises: (a) reducing a compound of Formula (2): to give a com...  
WO2005004803A3
The present invention is directed to compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention ...  
WO2004113391A3
The present invention is directed to methods of preparation of sulfonate derivatized compounds, e.g., 3-amino-l-propanesulfonic acid and 1,3-propanedisulfonic acid disodium salt with increased purity, with reduced potential for toxic by-...  
WO2003072063A3
Compounds useful as antiproliferative agents, including, for example, anticancer agents, are provided according to formula (I): wherein:Ar, X, X<1>, g, R and R<3> are as defined herein.  
WO2005003062A3
The invention aims at providing a process by which fluorinated sulfonyl fluorides having various molecular structures can be obtained efficiently and inexpensively with production problems solved. The invention provides a process which c...  
WO2004087623A3
A process for the preparation of (R)(-) Tamsulosin hydrochloride [(R)(-)-5-[2-[[2-(o-ethoxy-phenoxy)ethyl]amino]-2-methylethy l]-2-methoxybenzenesulfonamide hydrochloride] of formula (III), The (R)(-) Tamsulosin hydrochloride of formula ...  
WO2002096865A8
A process for the preparation of a compound of formula (I) in which R represents H or an acid protecting group which comprises reacting a compound of formula (II) in which R is as previously def ined with a compound of formula (III) wher...  
WO/2005/019164A2
The present invention relates to a novel process for the preparation of phenethanolamine derivatives, which process comprises the step of reacting a compound of formula RO(CH2)nBRaRb with a compound of formula (II).  
WO2004016578A8
The present invention concerns compounds of formula (I) and salts, solvates, and physiologically functional derivatives thereof, wherein: R<1> is hydrogen or -XSO2NR<6>R<7>; R<2> and R<3> are independently selected from hydrogen, C1-6 al...  
WO/2005/014539A2
HMGCo-A reductase inhibitor compounds of formula (I) useful as hypocholesterolemic and hypolipidemic compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compo...  
WO/2005/012238A1
A process for making a compound of formula (I) in which process the compound HC≡C-(CH2)n-NH2 is reacted with the compound R1-SO2Cl to produce an intermediate compound, which intermediate compound is then reacted with the compound of fo...  
WO/2005/012239A1
Provided are ionically dissociative functional molecules which are thermally and chemically stable under the conditions required for electrochemical equipment and useful as the material of protonic conductors of fuel cells; processes for...  
WO/2005/010011A2
Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in...  
WO/2005/007865A1
Optically active &agr -methylcysteine derivative is efficiently produced from an inexpensive raw material. An optically active 2-amino-2-methyl-1,3-propanediol derivative monoester is produced by esterifying one of the hydroxyls of 2-ami...  

Matches 651 - 700 out of 9,494